Special Issue "Appetite Regulation and Mitophagy with Links to Chronic Disease and Alzheimer’s Disease"
Deadline for manuscript submissions: 30 June 2019
Dr. Ian James Martins
Centre of Excellence in Alzheimer’s Disease Research and Care, School of Medical Sciences, Edith Cowan University, Joondalup, Australia
Website | E-Mail
Interests: Alzheimer's Disease; appetite regulation; environment; nutrition; senescence; accelerated disease; metabolism; type 3 diabetes; heat shock gene; mitochondrial biogenesis; autoimmune disease
Nutritional research has become important in appetite regulation with improvements in health relevant to healthy diets and the prevention of chronic disease and Alzheimer’s disease. Environmental factors such as stress, anxiety, and depression are important to consider with relevance to appetite dysregulation and the global increase in chronic diseases such as diabetes and neurodegenerative diseases. The origins of metabolic diseases may involve the dysregulation of hormones, nuclear receptors, and neuropeptides in the brain and peripheral tissues. Appetite disorders and brain metabolic diseases associated with obesity and diabetes require early intervention with diet, lifestyle, and drug therapy to prevent non-alcoholic fatty liver disease (NAFLD) and Alzheimer’s disease. The effects of overnutrition on appetite and core body temperature regulation induce autoimmune disease and mitophagy that are involved in programmed cell death in insulin resistance and Alzheimer’s disease. Nutritional research is now essential to promote mitochondrial biogenesis that is connected to appetite regulation in both chronic and neurodegenerative diseases. The links between appetite dysregulation, endocrinology, and metabolism implicate the peptide apelin and the nuclear receptor Sirtuin 1 (Sirt 1) to be defective and involved in NAFLD and Alzheimer’s disease. Appetite regulation is now critical to the prevention of brain disorder therapy that may involve the reversal of synaptic plasticity defects that link diabetes to neurodegenerative diseases.
Dr. Ian James Martins
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- anti-aging genes
- Alzheimer’s disease
- synaptic plasticity
- autoimmune disease
- chronic diseases